Biolife Solutions (BLFS) Shares Outstanding (Weighted Average) (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $48.5 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 2.81% year-over-year to $48.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.5 million (up 2.81% YoY) and the FY2025 annual result came in at $47.8 million, up 3.66% from the prior year.
• Shares Outstanding (Weighted Average) rose to $48.5 million in Q1 2026 per BLFS's latest filing, from $47.8 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $48.5 million in Q1 2026 and bottomed at $42.5 million in Q2 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $45.6 million (2024), against an average of $45.2 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) increased 13.92%; it then increased 2.16% in 2023.
• Tracing BLFS's Shares Outstanding (Weighted Average) over 5 years: stood at $42.5 million in 2022, then increased by 2.91% to $43.7 million in 2023, then increased by 5.37% to $46.1 million in 2024, then rose by 3.66% to $47.8 million in 2025, then climbed by 1.48% to $48.5 million in 2026.
• Per Business Quant, the three latest BLFS Shares Outstanding (Weighted Average) figures stand at $48.5 million (Q1 2026), $47.8 million (Q4 2025), and $47.6 million (Q3 2025).

Peer Comparison